Nord, an American independent asset management company? Lord Abbett &; Co. LLC (hereinafter referred to as "Lord Abbott") is a fund management company jointly funded by changjiang securities Limited Liability Company (hereinafter referred to as "changjiang securities") and Tsinghua Holdings Limited (hereinafter referred to as "Tsinghua Holdings"). The registered capital of the company is 6,543.80 billion yuan, of which Lord Abbott's contribution is equivalent to 49 million yuan. 49% of the shares, changjiang securities contributed 30 million yuan, accounting for 30% of the shares, and Tsinghua Holdings contributed 2 1 10,000 yuan, accounting for 2 1% of the shares. The company's headquarters is located at floor/0/2, Huiya Building, Lujiazui Ring Road, Pudong, Shanghai.

The company has a unique shareholder background in the industry. As a Sino-foreign joint venture fund management company, Nord Fund Management Co., Ltd. not only has an international investment expert, Lord Abbott, like other peers; Changjiang securities, a local investment expert with a background in Tsinghua University, has trained many China investment experts for international and domestic capital markets. This makes the company have the unique advantage of organically combining advanced investment experience and advanced investment theory, thus guiding the market investment fashion.

With the investment legend created by Lord Abbott, the company's controlling shareholder, for more than 70 years, the company's accumulated experience is being or will be shared by more company fund holders:

-During the difficult period from 1972 to 10 of 1982 in the US stock market, Lord Abbott's fund created an average return performance as high as 10.8%, while the average return of the Dow Jones Industrial Average was only 5.4% in the same period;

Even if investors invested in Lord Abbott's fund at the peak of the market, its long-term performance was quite good. For example, during the period from 1975 to 2004, investors invested the same funds in the fund at the highest and lowest points of the market and the first trading day of that year. By the end of 2004, the average annual return on investment was 12.52%, 13.49% and 13. 15% respectively.

Today, these investment wisdom has been implanted in Nord Fund Management Co., Ltd., which will make use of nearly a hundred years of successful overseas investment experience to manage money for domestic investors. The strategic plan for the company's development is to gradually change from a single fund management company to a multi-level and all-round asset management company, guided by open-end fund business and supplemented by various financial innovation businesses.

novo nordisk

The company is headquartered in Copenhagen, Denmark.

Is the world's leading biopharmaceutical company, committed to human health, with advanced biotechnology for the benefit of patients, doctors and society. Novo Nordisk has the widest range of diabetes treatment products in the industry, including the most advanced insulin delivery system products, and has been the world leader in diabetes research and drug development for more than 80 years. In addition, Novo Nordisk is also a world leader in hemostasis management, growth health hormone and hormone replacement therapy. Headquartered in Copenhagen, Denmark, Novo Nordisk now has branches in nearly 70 countries and production plants in 6 countries, with more than 265,438+0,000 employees and sales in 65,438+080 countries.